Literature DB >> 28853639

Acute vision loss in systemic lupus erythematosus: bilateral combined retinal artery and vein occlusion as a catastrophic form of clinical flare.

M Akhlaghi1, B Abtahi-Naeini2, M Pourazizi1.   

Abstract

Presentation of a combination of branch retinal artery occlusion (BRAO)/central retinal artery occlusion (CRAO) and central retinal vein occlusion (CRVO) in systemic lupus erythematosus (SLE) is extremely rare. Herein, we have presented the case of a 29-year-old female with SLE, who simultaneously developed bilateral CRVO and BRAO/CRAO in the absence of antiphospholipid syndrome (APS) as a catastrophic form of clinical flare. A combinatorial diagnosis of CRVO and BRAO/CRAO should be considered during clinical flare-up in a patient with SLE who presents with rapidly progressive visual loss.

Entities:  

Keywords:  Systemic lupus erythematosus; branch retinal artery occlusion; central retinal artery occlusion; central retinal vein occlusion; flare; vision loss

Mesh:

Substances:

Year:  2017        PMID: 28853639     DOI: 10.1177/0961203317727602

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

1.  Bilateral simultaneous Central Retinal Artery Occlusion (CRAO) in a patient with Systemic Lupus Erythematosus (SLE).

Authors:  Kiran Chandran; Shailaja Bhat Shenoy; Chidanand Kulkarni; Namitha Rachel Mathew
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-20

2.  Clinical Features of Combined Central Retinal Artery and Vein Occlusion.

Authors:  Hao Wang; Yongye Chang; Fen Zhang; Rong Yang; Suxia Yan; Jieying Dong; Minglian Zhang; Shaomin Peng
Journal:  J Ophthalmol       Date:  2019-10-09       Impact factor: 1.909

3.  Severe Vaso-Occlusive Retinopathy in Systemic Lupus Erythematosus: A Case Series.

Authors:  Kshitiz Kumar; Shouvick Dan; Tushar K Sinha; Debashish Bhattacharya
Journal:  Cureus       Date:  2021-01-30

4.  Central retinal artery and vein occlusion as a complication of persistent hyaloid artery - a case report.

Authors:  Mirjana Bjeloš; Ana Križanović; Mladen Bušić; Biljana Kuzmanović Elabjer
Journal:  BMC Ophthalmol       Date:  2020-11-03       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.